First-in-Class Regenerative Therapeutic for AD Promising First-in-Class Regenerative Therapeutic for AD Promising

Allopregnanolone has the potential to delay neurodegeneration in early Alzheimer ' s disease by promoting endogenous systems of renewal and repair, early testing shows.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news